快速胆固醇酶的改善作为抗类固醇耐药性免疫相关胆固醇炎的关键策略:一个病例报告
Zhao Gao1, Ji-Xin Zhang2, Xiao-Dong Tian3
1Department of Medical Oncology, Peking University First Hospital, Beijing 100034, China.
World journal of gastrointestinal oncology
|September 22, 2025
概括
免疫相关的胆脉炎,是免疫检查点抑制剂 (ICI) 的胆道阻塞并发症,通过支架安置得到改善. 当其他疗法失败时,这种局部治疗有效地缓解胆固醇,突显了其治疗重要性.
科学领域:
- 在瘤学瘤学.
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
背景情况:
- 免疫检查点抑制剂 (ICI) 可以引起与免疫相关的胆管炎,这是一种严重的疾病,涉及胆道阻塞.
- 虽然ICI治疗后报告了药物诱导的硬化性胆管炎,但局部阻塞缓解的有效性仍未得到充分研究.
研究的目的:
- 调查局部胆道阻塞缓解在类固醇耐药性免疫相关胆道炎的治疗重要性.
- 报告一个成功管理免疫相关胆管炎的病例,使用内镜支架植入.
主要方法:
- 一名胆道癌患者接受了抗PD-1和氨酸激酶抑制剂联合治疗,其肝酶水平升高.
- 诊断成像 (MRCP,EUS,ERCP,血管造影) 和活检证实了免疫相关的胆脉炎与胆道阻塞.
- 该患者接受了内镜逆行胆血管细胞造影 (ERCP) 与支架植入用于胆固醇病管理.
主要成果:
- 尽管用皮质类固醇和ursodeoxycholic acid治疗,胆道酶仍然升高.
- 内镜检查结果显示了常见的胆管异常,狭窄和炎症与免疫相关的胆管炎相一致.
- 支架安置导致肝功能正常化和症状改善.
结论:
- 通过支架安置进行局部治疗,可快速缓解免疫相关胆管炎中的胆管病变.
- 内镜支架植入是一种有效的治疗策略,用于管理这种ICI诱导的并发症.
相关概念视频
Chronic Pancreatitis II: Collaborative Care
315
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
315
Chronic Bowel Disorders: Introduction
747
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
747
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
493
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
493
Inflammatory Bowel Disease IV: Pharmacological Management
528
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
528


